NCT00374660 2021-12-08
Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
Eisai Inc.
Phase 1/2 Completed
Eisai Inc.
M.D. Anderson Cancer Center
University of Chicago
National Cancer Institute (NCI)
Eisai Inc.
The University of Texas Health Science Center at San Antonio